Results 91 to 100 of about 2,821 (202)

Cost-effectiveness analysis of antimuscarinics in the treatment of patients with overactive bladder in Spain: A decision-tree model [PDF]

, 2011
Background Fesoterodine, a new once daily antimuscarinic, has proven to be an effective, safe, and well-tolerated treatment in patients with overactive bladder (OAB).
Salvador Arlandis-Guzman, Arumi Daniel, Carlos Errando-Smet, Rejas Javier, Javier Rejas, Arlandis-Guzman Salvador, Daniel Arumi, Jeffrey Trocio, Trocio Jeffrey, Errando-Smet Carlos   +9 more
core   +2 more sources

Off-Target Effects of Mirabegron on Muscarinic Receptors

Future Pharmacology
Older adults with multiple diseases are likely to be prescribed multiple medications including anticholinergic agents, which are frequently prescribed to manage conditions such as overactive bladder and chronic obstructive pulmonary disease and Parkinson’
Shizuo Yamada, Masaki Mogi, Satomi Kagota, Kazumasa Shinozuka   +3 more
doaj   +1 more source

Anticholinergic drugs and dementia risk: Using stem cell–based studies to complement pharmacoepidemiology

Alzheimer’s & Dementia: Translational Research & Clinical Interventions
BACKGROUND Anticholinergic (AC) use remains common in older adults despite evidence of safety risks, including increased risk in dementia. Pharmacoepidemiology studies from various populations report associations between specific anticholinergic classes –
Tiara A. Schwarze‐Taufiq, Inez K. A. Pranoto, Katherine Hui, Chizuru Kinoshita, Onchee Yu, Paul K. Crane, Shelly L. Gray, Jessica E. Young   +7 more
doaj   +1 more source

Plant sources of antimuscarinics [PDF]

BJU International, 2015
openaire   +2 more sources

Bladder antimuscarinics in older adults: as bad as portrayed?

Continence
The use of antimuscarinics for overactive bladder in older adults has been affected by the results of epidemiological cross-sectional studies which have found an association between their use and the risk of an incident dementia diagnosis.
Adrian Wagg
doaj   +1 more source

New developments in the management of overactive bladder: focus on mirabegron and onabotulinumtoxinA

Therapeutics and Clinical Risk Management, 2013
Karl-Erik Andersson Institute of Regenerative Medicine, Wake Forest University School of Medicine, and Department of Urology, Wake Forest Baptist Medical Center, Winston Salem, NC, USA Abstract: In the last few years, much new information has been ...
Andersson KE
doaj  

Adverse Outcomes of Antimuscarinics in Elderly Dementia

, 2017
Background- Dementia and Overactive bladder (OAB) are one of the most common comorbid conditions affecting older patients. Pharmacological management of OAB involves use of antimuscarinic drugs.
Kachru, Nandita
core  

Adverse Outcomes of Antimuscarinics in Elderly Dementia

, 2018
Background- Dementia and Overactive bladder (OAB) are one of the most common comorbid conditions affecting older patients. Pharmacological management of OAB involves use of antimuscarinic drugs.
Kachru, Nandita
core  

Pharmacotherapy in overactive bladder

, 2017
Overactive bladder syndrome (OAB) has a high prevalence within the population and has a negative effect on quality of life. Although the precise pathophysiology has yet to be fully elucidated, pharmacotherapeutic agents have been developed targeting two ...
I Pearce, VCG Hopkinson
core   +1 more source

Ice Water Test Unmasks Detrusor Overactivity in Apparently Normal Conventional Cystometry. [PDF]

Eur Urol Open Sci
Stächele L, Sadri H, Anderson CE, Birkhäuser V, Gross O, Lehner F, Leitner L, Liechti MD, Mehnert U, Kessler TM.   +9 more
europepmc   +1 more source